NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner
Open Access
- 12 March 2022
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 12 (3) , 438
Abstract
The p53 family has the following three members: p53, p63 and p73. p53 is a tumor suppressor gene that frequently exhibits mutation in head and neck cancer. Most p53 mutants are loss-of-function (LoF) mutants, but some acquire some oncogenic function, such as gain of function (GoF). It is known that the aggregation of mutant p53 can induce p53 GoF. The p73 activators RETRA and NSC59984 have an anti-cancer effect in p53 mutation cells, but we found that p73 activators were not effective in all head and neck squamous cell carcinoma (HNSCC) cell lines, with different p53 mutants. A comparison of the gene expression profiles of several regulator(s) in mutant HNSCC cells with or without aggregation of p53 revealed that nicotinamide phosphoribosyltransferase (NAMPT) is a key regulator of mutant p53 aggregation. An NAMPT inhibitor, to reduce abnormal aggregation of mutant p53, used in combination with a p73 activator, was able to effectively repress growth in HNSCC cells with p53 GoF mutants. This study, therefore, suggests a potential combination therapy approach for HNSCC with a p53 GoF mutation.Keywords
This publication has 53 references indexed in Scilit:
- Enzymes in the NAD+ Salvage Pathway Regulate SIRT1 Activity at Target Gene PromotersJournal of Biological Chemistry, 2009
- NetCSSP: web application for predicting chameleon sequences and amyloid fibril formationNucleic Acids Research, 2009
- Stress-Inducible Regulation of Heat Shock Factor 1 by the Deacetylase SIRT1Science, 2009
- Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathwayProceedings of the National Academy of Sciences, 2008
- The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammalsCurrent Opinion in Gastroenterology, 2007
- The functional domains in p53 family proteins exhibit both common and distinct propertiesCell Death & Differentiation, 2006
- How Many Mutant p53 Molecules Are Needed To Inactivate a Tetramer?Molecular and Cellular Biology, 2004
- A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core DomainMolecular and Cellular Biology, 2001
- Identification of genomic DNA sequences bound by mutant p53 protein (Gly245→Ser) in vivoOncogene, 2000
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989